Nurix Therapeutics, Inc.
NRIX
$15.60
-$0.13-0.83%
NASDAQ
| 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -78.22M | -86.42M | -43.46M | -56.35M | -58.55M |
| Total Depreciation and Amortization | 4.03M | 5.00M | 5.10M | 4.13M | 3.00M |
| Total Amortization of Deferred Charges | 600.00K | -- | -- | -- | 1.30M |
| Total Other Non-Cash Items | 7.31M | 7.58M | 7.68M | 5.17M | 5.05M |
| Change in Net Operating Assets | -1.55M | 16.46M | -32.48M | -14.03M | 449.00K |
| Cash from Operations | -67.83M | -57.39M | -63.16M | -61.09M | -48.75M |
| Capital Expenditure | -5.13M | -2.71M | -2.68M | -3.49M | -2.11M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 5.48M | 53.19M | 74.17M | 29.02M | -138.71M |
| Cash from Investing | 346.00K | 50.48M | 71.50M | 25.53M | -140.82M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 236.01M | 1.16M | 6.00K | 1.47M | 200.52M |
| Repurchase of Common Stock | -- | -- | -- | -- | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 236.01M | 1.16M | 6.00K | 1.47M | 200.52M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 168.52M | -5.76M | 8.34M | -34.08M | 10.95M |